Laila‐Yasmin Mani

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology · 2021 · 243 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +12

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study

Matthias B. Moor, Franziska Suter‐Riniker, Michael P. Horn et al. · The Lancet Rheumatology · 2021 · 211 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 172 citations · Full text

Life Sciences, Bioinformatics, Nephrology +17

Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy

Daniel Sidler, Alexander Born, Simeon Schietzel et al. · RMD Open · 2022 · 19 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17